ENCOMPASS LLC - THE INITIAL SUB OBLIGATION OF $6,000,000.37 WILL COVER UP TO 24 MONTHS FOR CLIN 1 ($16,000,000) OF FUNDING WHICH IS IN COMPLIANCE WITH FORWARD FUNDING POLICY. THE MONITORING, EVALUATION AND LEARNING (MEL) MECHANISM IS A 5-YEAR INSTRUMENT TO BE MANAG
Key Details
Description
THE INITIAL SUB OBLIGATION OF $6,000,000.37 WILL COVER UP TO 24 MONTHS FOR CLIN 1 ($16,000,000) OF FUNDING WHICH IS IN COMPLIANCE WITH FORWARD FUNDING POLICY. THE MONITORING, EVALUATION AND LEARNING (MEL) MECHANISM IS A 5-YEAR INSTRUMENT TO BE MANAG
Context & Analysis
On Sep 29, 2022, Agency for International Development obligated $10,707,215.16 to ENCOMPASS LLC for the initial sub obligation of $6,000,000.37 will cover up to 24 months for clin 1 ($16,000,000) of funding which is in compliance with forward funding policy. the monitoring, evaluation and learning (…. The award is classified under NAICS 541990 — ALL OTHER PROFESSIONAL, SCIENTIFIC, AND TECHNICAL SERVICES. Competition extent: full and open competition after exclusion of sources with 4 offers received. This award is one of several similar procurements from Agency for International Development under NAICS 541990 — related awards are listed below.
Contractor Information
Similar Awards
IN PARTNERSHIP WITH PROSPER AFRICA, FEED THE FUTURE, AND OTHER INITIATIVES, THE USAID AFRICA BUREAU, AFRICA REGIONAL MISSIONS, AND THE MIDDLE EAST BUREAU ARE JOINTLY ESTABLISHING THE PROSPER AFRICA TRADE AND INVESTMENT (PATI) ACTIVITY. THE PURPOSE O
DAI GLOBAL LLC
$360.7M
IN PARTNERSHIP WITH PROSPER AFRICA, FEED THE FUTURE, AND OTHER INITIATIVES, THE USAID AFRICA BUREAU, AFRICA REGIONAL MISSIONS, AND THE MIDDLE EAST BUREAU ARE JOINTLY ESTABLISHING THE PROSPER AFRICA TRADE AND INVESTMENT (PATI) ACTIVITY. THE PURPOSE O
DAI GLOBAL LLC
$360.7M
IN PARTNERSHIP WITH PROSPER AFRICA, FEED THE FUTURE, AND OTHER INITIATIVES, THE USAID AFRICA BUREAU, AFRICA REGIONAL MISSIONS, AND THE MIDDLE EAST BUREAU ARE JOINTLY ESTABLISHING THE PROSPER AFRICA TRADE AND INVESTMENT (PATI) ACTIVITY. THE PURPOSE O
DAI GLOBAL LLC
$357.9M
EFFICIENCIES FOR CLINICAL HIV OUTCOMES (ECHO) ACTIVITY IN MOZAMBIQUE
ABT GLOBAL LLC
$253.9M
EFFICIENCIES FOR CLINICAL HIV OUTCOMES (ECHO) ACTIVITY IN MOZAMBIQUE
ABT GLOBAL LLC
$239.6M
Stay Updated
Get notified about new opportunities matching your interests.